logo-loader

Concarlo Holdings using technology to fight drug resistance issues in breast cancer

Published: 11:35 11 Jan 2019 EST

Concarlo Holdings LLC Chief Scientific Officer Stacy Blain sat down with Christine Corrado from Proactive Investors at the 11th Annual Biotech Showcase in San Francisco. The Brooklyn, New York, company uses patented technologies to combat drug resistance in the treatment of breast cancer.
 

Xeris Biopharma Surpasses 2023 Expectations with Strategic Moves Poised for...

Xeris Biopharma CEO Paul Edick joined Steve Darling from Proactive to share news the company had a successful 2023, with a final tally of 164 million USD, which is at the upper end of their forecast. The company concluded the year with 72 million USD in cash, surpassing their initial projections...

7 hours, 25 minutes ago